Value of bevacizumab in treatment of colorectal cancer: A meta-analysis

doi:10.3748/wjg.v21.i16.5072

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 16

This Article

(287)

(288)

(0)

(8199)

(63)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Meta-Analysis

World J Gastroenterol. Apr 28, 2015; 21(16): 5072-5080
Published online Apr 28, 2015. doi: 10.3748/wjg.v21.i16.5072

Full Size Figure Download Figure

Figure 10 Assessment of publication bias. All studies are evenly distributed on both sides, thus presenting basic symmetry and indicating that there was no publication bias in the 10 reports.

Citation: Qu CY, Zheng Y, Zhou M, Zhang Y, Shen F, Cao J, Xu LM. Value of bevacizumab in treatment of colorectal cancer: A meta-analysis. World J Gastroenterol 2015; 21(16): 5072-5080
URL: https://www.wjgnet.com/1007-9327/full/v21/i16/5072.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i16.5072

Qu CY, Zheng Y, Zhou M, Zhang Y, Shen F, Cao J, Xu LM. Value of bevacizumab in treatment of colorectal cancer: A meta-analysis. World J Gastroenterol 2015; 21(16): 5072-5080 [PMID: 25945023 DOI: 10.3748/wjg.v21.i16.5072]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.